Evaluation of Biological Biomarkers Diagnostic of Toxoplasmosis Uveitis

NCT02843438 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

72

Enrollment

OTHER

Sponsor class

Conditions

Subjects Clinically Suspected an Active Source of Toxoplasmosis Chorioretinitis Infection

Interventions

OTHER: Fluorescein angiography
OTHER: Dilated fundus examination
BIOLOGICAL: Toxoplasmosis serology
DRUG: Anti-toxoplasmosis treatment
DRUG: Anti-inflammatory treatments
OTHER: Puncture in anterior chamber

Sponsor

University Hospital, Grenoble